Monoshot™ HA+PRP is a combination of hyaluronic acid (HA) with platelet-rich plasma (PRP), intended for intra-articular injection. Product provides simultaneous mechanical and anti-catabolic action of HA with optimally selected physicochemical parameters and the anabolic action of growth factors secreted by platelets from PRP. Thus, clinical effectiveness of the therapy based on Monoshot™ HA+PRP is strictly linked to the combined action provided by each of its component- HA and growth factors released by PLTs.
Monoshot™ HA, with selected optimal viscoelastic properties provides not only the mechanical effect, like improved lubrication and adsorption of forces acting in the joint, but it also offers the antiinflammatory effect by reduction of tissue-degrading enzymes production, such as matrix metalloproteinases1. On the other hand, PRP obtained with the Monoshot™ PRP separation device is a highly concentrated PLT solution, characterized by platelets concentration way above 1 000 000 PLT/µl- a threshold of a therapeutical effectiveness for PRP2. Growth factors secreted by such high number of PLTs in PRP provide a robust anabolic effect, initiating regeneration and rebuilding process of damaged tissues3.
Simultaneous intra-articular injection of HA and PRP delivers the combined and strengthened action of both kit components.
Monoshot™ HA, with selected optimal viscoelastic properties provides not only the mechanical effect, like improved lubrication and adsorption of forces acting in the joint, but it also offers the antiinflammatory effect by reduction of tissue-degrading enzymes production, such as matrix metalloproteinases1. On the other hand, PRP obtained with the Monoshot™ PRP separation device is a highly concentrated PLT solution, characterized by platelets concentration way above 1 000 000 PLT/µl- a threshold of a therapeutical effectiveness for PRP2. Growth factors secreted by such high number of PLTs in PRP provide a robust anabolic effect, initiating regeneration and rebuilding process of damaged tissues3.
Simultaneous intra-articular injection of HA and PRP delivers the combined and strengthened action of both kit components.